http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BG-110468-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
filingDate 2002-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2010-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BG-110468-A
titleOfInvention Treatment of neurotic disorders
abstract The present invention relates to the use of (S-(+)-enantiomer of citalopram) or its pharmaceutically acceptable salt for the production of medicinal preparation, useful for treatment of neurotic disorders including anxiety conditions, particularly generalized anxiety disorder and social anxiety disorder, post-traumatic stress disorder, obsessive-compulsive disorder and panic attacks.
priorityDate 1999-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507269
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29922413
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493337
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426266256

Total number of triples: 26.